secwatch.observer — SEC 8-K summary
======================================

Issuer:     Barinthus Biotherapeutics plc. (BRNS)
CIK:        0001828185
Form:       8-K
Filed at:   2022-09-20T23:59:59+00:00
Accession:  0001104659-22-101580
Event type: leadership
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Vaccitech promotes Gemma Brown to CFO, replacing Georgy Egorov
--------------------------------------------------------------

- Gemma Brown, previously Head of Financial Reporting, appointed CFO effective Sept 15, 2022; age 32.
- She receives £220k base salary and is eligible for annual bonus up to 40% of base.
- Prior CFO Georgy Egorov terminated Sept 14, 2022; termination unrelated to financials or controls.
- Egorov receives six months base salary severance; Brown entitled to similar payment on termination.
- Brown joined Vaccitech in Sept 2021; prior experience as Senior Manager at EY.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1828185/000110465922101580/0001104659-22-101580-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1828185/000110465922101580/tm2226233d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-22-101580

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer